Additively manufactured titanium test specimens

The Food and Drug Administration is seeking additively manufactured titanium test specimens to support ongoing research into the variability of 3D-printed devices. This initiative stems from stakeholder engagement identifying device variability as a critical area of study, and the requested specimens are essential for the characterization and investigation of these materials. Currently listed as a forecast, the opportunity is managed by the Food and Drug Administration. Interested parties can coordinate through the CDRH Acquisition Liaison, although a specific contracting officer has not yet been designated.